Enliven is now concentrated on ELVN-001, a Phase 1 program. ELVN-002 is no longer in development, so the investment case has become a single-program clinical thesis.. Wait; flows conflict. Wait state: Break above $61.80.
Enliven is now concentrated on ELVN-001, a Phase 1 program. ELVN-002 is no longer in development, so the investment case has become a single-program clinical thesis.
| Metric | Value | Signal |
|---|---|---|
| Revenue (TTM) | $0 | 0.0% YoY |
| EBITDA | N/A | Not meaningful / unavailable |
| Gross Margin | 0.0% | Reported |
| Operating Margin | N/A | Not meaningful without revenue |
| Net Margin | N/A | Not meaningful without revenue |
| ROE | -15.3% | Capital efficiency |
| Cash | $895.2M | Liquidity |
| Debt | $1.5M | Balance-sheet claim |
| Forward P/E | N/A | No estimate substituted |
| Intrinsic-value model | N/A | Fail-closed: insufficient inputs |
| Value / quality panel | 0 positive / 5 negative / 0 neutral | bearish / confidence 55 |
| Analyst Mean Target | $73.90 | Consensus, not a guarantee |
| Quarter | EPS Actual | EPS Est. | Surprise | Revenue |
|---|---|---|---|---|
| 3Q2025 | $-0.32 | $-0.47 | 31.2% | - |
| 4Q2025 | $-0.48 | $-0.47 | -1.1% | - |
| 1Q2026 | $-0.38 | $-0.41 | 7.3% | - |
| 2Q2026 | $-0.49 | $-0.38 | -29.8% | - |
2/4 captured quarters beat estimates — Next: 2026-11-11T20:00:00Z
No structured transaction table was captured; aggregate counts are not used.
| Series | Type | Strike | Shares | Exp. | Dilution | Status |
|---|---|---|---|---|---|---|
| Pre-funded | Outstanding warrants | N/A | 4.585M | N/A | Aggregate outstanding pre-funded warrants | Outstanding |
Authorized: $200M | Used: Not stated in this review | Remaining: $200M disclosed as available
The June offering raised $460M gross through 10.53M shares and 1.73M warrants. A $200M ATM remains available, 4.585M pre-funded warrants are outstanding and authorized shares doubled to 200M.
Official filings were reviewed through 2026-08-28; the table lists the decision-relevant documents rather than every routine filing. The C+ grade describes the full dossier; the trade state (wait) is a separate timing decision.
| Date | Form | Accession | What the filing changes |
|---|---|---|---|
| 2026-08-05 | 10-Q | 0001193125-26-335155 | Reports $895.2M liquidity and management runway guidance through 2030. |
| 2026-06-12 | 424B5 | 0001193125-26-269621 | Documents the June equity and warrant financing. |
| 2025-08-13 | S-3ASR | 0001193125-25-179946 | Establishes shelf and ATM capacity. |
Current snapshot only; no acceleration claim without a comparable historical series.
Unusual Activity: No unusual activity confirmed
| RSI (14) | 63.2 |
| EMA 20 | $58.73 |
| EMA 50 | $54.30 |
| EMA 200 | $39.82 |
| MACD | 1.965 |
| Signal | 2.167 |
| ATR (14) | $2.29 |
| Wyckoff | Transitional |
Wait; flows conflict. Required confirmation: Break above $61.80. Available moving averages are shown with their provider type.
| Indicator | Value | Signal |
|---|---|---|
| Market regime | Risk-on 0.79 | Trend support, not a timing trigger |
| VIX | 14.51 | Low current protection price |
Regime: risk-on
The broad regime supports long setups, but rates and ticker-specific confirmation override the label.
Dilution: high; beta: 0.24; insider signal: unavailable.
A precise stop does not make a setup valid. Entry location, normal volatility, event risk and reachable resistance decide whether the risk is paid.
No directional flow claim is made when detailed, aligned flow data is unavailable.
Wait; flows conflict. Monitor break above $61.80; no market order and no chase outside the zone.
Wait for confirmation and preserve the invalidation.
This analysis is provided for informational and educational purposes only. It does not constitute financial advice, investment recommendation, or solicitation to buy or sell any security.
Past performance is not indicative of future results. All investments involve risk, including the possible loss of principal. Always conduct your own research and consult a licensed financial advisor before making investment decisions.
Data comes from point-in-time market snapshots, company filings, Yahoo Finance, SEC EDGAR, and public market data. Accuracy is not guaranteed.
Social Radar
Pump & Dump Score: 3/6
Suspect